Maxcyte (MXCT) Current Deferred Revenue (2020 - 2026)
Maxcyte (MXCT) posted quarterly Current Deferred Revenue of $3.3 million for Q1 2026, down 21.09% year-over-year from $4.1 million in Q1 2025, and down 9.09% quarter-over-quarter from $3.6 million in Q4 2025.
Maxcyte (MXCT) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Current Deferred Revenue for 7 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 21.09% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 21.09% YoY), while the FY2025 annual figure was $3.6 million, down 31.48% from the prior year.
- Current Deferred Revenue eased to $3.3 million in Q1 2026 per MXCT's latest filing, from $3.6 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $7.3 million in Q2 2022 and bottomed at $2.6 million in Q2 2025.
- Historically, Current Deferred Revenue has averaged $5.1 million across 5 years, with a median of $5.2 million in 2025.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue sank 35.81% — and 2024, when it grew 19.1%.
- Maxcyte's Current Deferred Revenue stood at $6.7 million in 2022, then decreased by 24.49% to $5.1 million in 2023, then advanced by 3.59% to $5.3 million in 2024, then sank by 31.48% to $3.6 million in 2025, then slipped by 9.09% to $3.3 million in 2026.
- Business Quant data shows MXCT's Current Deferred Revenue at $3.3 million in Q1 2026, $3.6 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | Maxcyte | 149.55 Mn | 149.55 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 5.25 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 4.48 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 6.29 Mn |
| Jun 30, 2022 | 7.31 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Dec 31, 2021 | 6.75 Mn |
| Sep 30, 2021 | 6.33 Mn |